PL3723778T3 - Kompozycja do stosowania w leczeniu opóźnionej kolonizacji przez bifidobacterium po urodzeniu - Google Patents

Kompozycja do stosowania w leczeniu opóźnionej kolonizacji przez bifidobacterium po urodzeniu

Info

Publication number
PL3723778T3
PL3723778T3 PL18816023.8T PL18816023T PL3723778T3 PL 3723778 T3 PL3723778 T3 PL 3723778T3 PL 18816023 T PL18816023 T PL 18816023T PL 3723778 T3 PL3723778 T3 PL 3723778T3
Authority
PL
Poland
Prior art keywords
bifidobacterium
colonization
birth
composition
treating delayed
Prior art date
Application number
PL18816023.8T
Other languages
English (en)
Inventor
Christophe LAY
Jan Knol
Kaouther Ben Amor
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL3723778T3 publication Critical patent/PL3723778T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18816023.8T 2017-12-11 2018-12-07 Kompozycja do stosowania w leczeniu opóźnionej kolonizacji przez bifidobacterium po urodzeniu PL3723778T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17206447 2017-12-11
PCT/EP2018/083949 WO2019115382A1 (en) 2017-12-11 2018-12-07 Composition for use for treating delayed colonization by bifidobacterium after birth

Publications (1)

Publication Number Publication Date
PL3723778T3 true PL3723778T3 (pl) 2025-06-02

Family

ID=60673270

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18816023.8T PL3723778T3 (pl) 2017-12-11 2018-12-07 Kompozycja do stosowania w leczeniu opóźnionej kolonizacji przez bifidobacterium po urodzeniu

Country Status (5)

Country Link
EP (1) EP3723778B1 (pl)
CN (1) CN111447936A (pl)
ES (1) ES3024358T3 (pl)
PL (1) PL3723778T3 (pl)
WO (1) WO2019115382A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023216181A1 (en) 2022-05-12 2023-11-16 N.V. Nutricia Improving micriobiota of infants born by caesarean section
CN114949006A (zh) * 2022-06-10 2022-08-30 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备缓解卵清蛋白诱导的食物过敏药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
ES2656776T3 (es) * 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
WO2014070016A2 (en) * 2012-11-02 2014-05-08 N.V. Nutricia Synbiotics combination for brain improvement
EP3237235A4 (en) * 2014-12-17 2018-07-25 Bridgestone Americas Tire Operations, LLC Tire sidewalls including high molecular weight waxes
WO2016183535A1 (en) * 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns

Also Published As

Publication number Publication date
CN111447936A (zh) 2020-07-24
ES3024358T3 (en) 2025-06-04
EP3723778A1 (en) 2020-10-21
WO2019115382A1 (en) 2019-06-20
EP3723778C0 (en) 2025-02-12
EP3723778B1 (en) 2025-02-12

Similar Documents

Publication Publication Date Title
IL258497B (en) Preparations for the treatment of sma muscular dystrophy
SG11201705093UA (en) Composition for treating il-6-related diseases
GB201715639D0 (en) Compositions for wound treatment
AP2017009674A0 (en) Methods and compositions for treating ulcers
SG11201700621XA (en) Antibiotic compositions for treating bacterial infections
EP3555360A4 (en) COMPOSITION FOR TREATMENT OF FABRICS
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
PT3261644T (pt) Composições e métodos para tratar a degradação retinal
EP3310385A4 (en) Methods and compositions for treating fibrotic diseases
IL276921A (en) Methods for changing body composition
SMT202200494T1 (it) Composizioni e metodi per il trattamento delle ferite
ZA201804478B (en) Methods and compositions for treating gastric ulcers
IL249640A0 (en) Preparations for the treatment of nosebleeds
PL3253395T3 (pl) Preparat probiotyczny do leczenia zapalenia jelit
ZA201503474B (en) Compositions and methods for treating bacterial infections
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
ZA201907283B (en) Compositions, devices and methods for treating autism
IL269743A (en) Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions
PL3723778T3 (pl) Kompozycja do stosowania w leczeniu opóźnionej kolonizacji przez bifidobacterium po urodzeniu
SG11201802292UA (en) Composition for treating pain
EP3212183A4 (en) Synergistic compositions for treating microbial infections
SI3548006T1 (sl) Sestava za uporabo pri zdravljenju črevesnih sprememb
PL3129031T3 (pl) Kompozycja do terapii zaburzeń żołądkowych
ZA201805215B (en) Preparation for nasal-nasopharyngeal treatment
AU2015903720A0 (en) Body treatment composition